Nabumetone Tablet
Product Images NDC 76420-210

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 76420-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

The text appears to be a list of medication information including the brand name 'Nabumetone Tablets, USP 500mg,' NDC numbers, quantities, lot numbers, and manufacturer names such as 'SeisGen Phamaceutss.' The text contains instructions on proper storage and warnings about the drug's impact on children.*

FDA Label Image

Figure1 (Figure1)

This is a chart showing plasma concentrations of the active metabolite (BMNA) of Nabumetone at steady state following the once-daily dosing of 1000 mg (n=31) and 2000 mg (n=12) in subjects. The x-axis represents the time in hours and the y-axis represents the concentration of the active metabolite in plasma. There are multiple dosing schedules depicted in the chart with different colors and line patterns. The text provides information on the dosages and number of subjects for each dosing schedule.*

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

6-methoxy-2-naphthylacetic acid (SMNA) is a chemical compound with the molecular formula C14H12O3. The compound contains a COOH group and a CHgO group.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.